Register HERE! The path forward for psychedelics will not mirror that of cannabis, although one similarity may be rapid industry growth. A byproduct of that growth will be mergers and acquisitions. Join Harris Bricken attorneys Hilary Bricken and Mason Marks as they present during the second annual Psychedelic Opportunity Summit‘s Psychedelic M&A Trends panel on
Two months ago we posted to celebrate the passage by Mexico’s Lower Chamber of the Cannabis Law bill sent to it by the Mexican Senate last November. In that post, I wrote, “The Law will now return to the Mexican Senate, where it is expected to be approved pretty much as written, at which point,
On Tuesday, June 8, the Brazilian Chamber of Deputies’ Special Commission very narrowly approved a bill authorizing cannabis cultivation for medicinal, veterinary, scientific, and industrial use. Government supporters tried their best to prevent the legislation from heading to the upper house for final approval, but Deputy Luciano Ducci’s crucial vote ensured the bill survived. While
A recent decision in the case of Elevations Plus, LLC v. City Council of Riverbank, in the Eastern District of California, reminded me of something: when undergoing administrative proceedings, always know the relevant statute of limitations. Statute of limitations are laws that determine the expiration date of a claim. In theory, they make sense and
So you’re interested in applying for an adult-use cannabis license once the Cannabis Control Board (CCB) issues the license application. One of the first decisions an applicant needs to make is where they intend to operate. As we referenced in our earlier posts on the Marijuana Regulation and Taxation Act (MRTA) and Part 1 of
Earlier this year, I wrote a post entitled “California May Decriminalize Psychedelics”. My post discussed a piece of legislation that was introduced (SB-519), which would decriminalize a host of psychedelic drugs. You can read about what exactly SB-519 would do in my prior post, but I want to again emphasize that the bill in its
Buying a cannabis business does not occur in a matter of days, and transactions fall apart for a variety of reasons, as we discussed in Part 1 of this blog series focused on the buy-side of a cannabis M&A transaction. In Part 2, we focused on the regulatory environment, discussing concepts that first-time buyers and their attorneys should
It’s been nearly a year since I wrote about litigation in the middle of COVID-19 , and I think it’s fair to say 2021 has been quite the busy year so far. Most litigation forecasts predicted this year would see a huge uptick in litigation – stemming from new circumstances created by COVID, as well
Our firm has seen a recent increase in ketamine clinic clients, both domestic and foreign (including for ketamine clinic buyers engaged in M&A, see here and here). In both camps, certain questions keep cropping up regarding starting, operating, and managing a ketamine clinic venture in the states. And what’s abundantly clear is that many people
Back in April, we discussed Florida law enforcement’s concerns over THC edibles whose packaging infringed on the trademarks of famous candy brands. These fakes have the potential to confuse consumers, as well as help minors conceal their use of THC products. We revisited the topic earlier this month, when we argued that the USPTO’s refusal
